|
|
|
|
Diet Drug
News articles on
Diet Drug
Fayette man draws 18 months in prison in Fen-Phen case 01 Apr 2005 Buie of Fayette has been ordered to serve an 18-month federal prison sentence for filing a false claim and receiving $250,000 in a diet drug lawsuit settlements ... Biloxi Sun Herald, The stereotpe of the rape-able woman 01 Apr 2005 Women have the majority of the buying power." If what she's saying is that the cosmetic surgery and diet drug industries strongly support our economy, then I ... New Hampshire (subscription), Special judge to be appointed in lawsuit over fen-phen settlement 01 Apr 2005 The case was transferred last month to Boone Circuit Court, where the original fen-phen lawsuit against diet-drug maker American Home Products was settled in ... WKYT, $5.5 M Awarded to Victims of Diet Drug ‘Fen-phen’ as Suits ... Mar 31, 2005 Mar 31 - Pharmaceutical company Wyeth will have to pay $5.5 million in damages to two plaintiffs as lawsuits involving withdrawn diet drug Pondimin continue to ... The NewStandard, Federal District Court Approves Seventh Amendment to National Diet ... Mar 19, 2005 Bartle III of the US District Court for the Eastern District of Pennsylvania has approved the proposed Seventh Amendment to the National Diet Drug Settlement. ... I-Newswire.com (press release) Research: Diet drug helps keep pounds off Mar 9, 2005 By Marilynn Marchione. ORLANDO, Fla. - A second study confirms that an experimental diet pill can help people lose weight and keep ... Myrtle Beach Sun News, Wyeth and Lawyers Representing Diet Drug Plaintiffs Advance ... Mar 1, 2005 Wyeth today said that plaintiffs’ attorneys representing a substantial number of claimants who have opted out of the National Diet Drug Settlement have ... mysan.de (Pressemitteilung), Wyeth wins Philadelphia diet drug trial Feb 25, 2005 ...bring extra relief to Wyeth, which has already recorded suffering a loss in its 2004 fourth quarter, due in part to costs relating to the diet drug litigation. ... Pharmaceutical Business Review Wyeth Wins Philadelphia Diet Drug Trial Feb 27, 2005 Wyeth (NYSE:WYE) announced today that the jury in the cases of Melinda Hoyt v. Wyeth and DaLene Marlowe v. Wyeth in the Court of Common Pleas in Philadelphia ... I-Newswire.com (press release) Wyeth and Lawyers Representing Diet Drug Plaintiffs Advance ... Feb 28, 2005 WYE - News) today said that plaintiffs' attorneys representing a substantial number of claimants who have opted out of the National Diet Drug Settlement have ... Yahoo News (press release) US Weight Loss Market Worth $46.3 Billion in 2004 — Forecast to ... Mar 31, 2005 The prescription diet drug closest to market is Rimonabant, which should hit the US market in 2006," according to Research Director John LaRosa. ... News Target, Some Coca Economics Mar 28, 2005 As a result of illegalization, the Prescription Diet Drug Industry is protected from competition by armies of armed government agents. ... The Narco News Bulletin Elan and Biogen Idec shares hammered late Mar 30, 2005 ...orders. Wyeth (WYE) shares were flat at $41.92 after it said it has received a split verdict in its four Philadelphia diet drug cases. ... Investor's Business Daily (subscription) The man who's behind Merck's Vioxx defense Mar 28, 2005 ...said Merck would not follow the example of Wyeth, which set up a trust fund to compensate injured patients after its "fen-phen" diet-drug combination was shown ... Philadelphia Inquirer, Mike Fancher / Times executive editor Interplay of power ... Mar 27, 2005 That I wrote a book ("Dispensing With The Truth" in 2001) about the fen-phen diet-drug disaster, showing what the drug company really knew and when it knew it. ... Seattle Times The Claims Facilitating Committee Announces Enthusiastic Support ... Mar 1, 2005 This settlement process was presented less than 30 days ago to the Federal Judge overseeing all Class Members in the Diet Drug Litigation, the Honorable Harvey ... mysan.de (Pressemitteilung), Diet Pill Acomplia Keeps the Pounds Off Mar 8, 2005 March 8, 2005 (Orlando) - The experimental diet drug Acomplia helps keep off unwanted pounds for up to two years, new research shows. ... WebMD Pre-trial process for Vioxx litigation begins Mar 18, 2005 To date, another pharmaceutical maker, Madison, NJ-based Wyeth, is facing the largest legal exposure from a drug, for its diet drug combination known as fen ... Miami Herald, Pre-Trial Hearing Begins for Vioxx Case Mar 18, 2005 To date, another pharmaceutical maker, Wyeth, is facing the largest legal exposure from a drug, for its diet drug combination known as fen-phen. ... ABC News Wyeth expects 1Q earnings to beat view Mar 21, 2005 Call. In 2004, Wyeth earned 91 cents a share after it reserved money to handle diet-drug litigation and other items hurt results. ... Miami Herald, Fen-Phen defendant avoids jail Mar 24, 2005 2004. She had submitted false claims to get paid for taking the diet drug Redux, Assistant US Attorney Richard Starrett said. Charges ... Jackson Clarion Ledger, Fayette woman sentenced to 18-months in Fen-Phen fraud case Mar 18, 2005 ...- A Fayette woman will serve 18 months in prison after pleading guilty to filing a false claim and receiving $250,000 in a diet drug lawsuit settlement. ... Biloxi Sun Herald, Verdict Set Aside by Judge, Jury Finds in Favor of Wyeth in ... Feb 26, 2005 Like many of the other cases being handled in the Philadelphia Complex Litigation Center's diet drug mass tort program, Hoyt and Marlowe were reverse-bifurcated ... New York Law Journal, Fayette woman sentenced to 6 months of home confinement in Fen ... Mar 1, 2005 ...six months home confinement and placed on three years probation for her role in a scheme to submit phony claims in a $400 million Fen-Phen diet-drug settlement ... Jackson Clarion Ledger, Fayette woman sentenced to home confinement in fen-phen probe Mar 1, 2005 ...- A Fayette woman received home confinement and probation after she admitted to submitting false claims in a $400 million fen-phen diet drug settlement. ... Biloxi Sun Herald, Playing Out the String of Fen-Phen's Yo-Yo Settlement Mar 16, 2005 In a ruling that promises to rescue the fen-phen diet drug settlement from a quagmire of satellite litigation, a federal judge has granted final approval to an ... New York Law Journal, Rising oil prices make investors nervous Mar 20, 2005 Wyeth said it got a federal judge's approval to add $1.3 billion to a $3.75 billion national settlement of lawsuits over the fen-phen diet-drug combination. ... Asbury Park Press, US CREDIT- Elan could narrow after getting hit Mar 2, 2005 Wyeth meanwhile has taken some $21 billion in charges since 1997 in settling lawsuits over fen-phen, a diet drug cocktail that was linked heart valve damage ... Reuters S&P: Still Hold Retek Mar 22, 2005 While we like Wyeth's research and development pipeline, we remain concerned over its still uncapped diet drug liability and patent expirations over the next ... BusinessWeek Last Fen-Phen defendants plead guilty Mar 2, 2005 ...the federal Fen-Phen investigation pleaded guilty Tuesday and another defendant was sentenced for filing a false claim in the $400 million diet-drug settlement ... Jackson Clarion Ledger, Indiscreet E-Mail Claims a Fresh Casualty Mar 8, 2005 ...who wrote an e-mail referring to "fat people who are a little afraid of some silly lung problem" -- a reference to the fact that some diet-drug users had ... Wall Street Journal (subscription), Teenage meth use rising in area Mar 14, 2005 ...night. It causes loss of appetite, so girls often use it as a diet drug. It's a sexual stimulant, so many take it before having sex. ... Pasadena Star-News, Woman draws 10 months in Fen-Phen fraud case Mar 10, 2005 ...charged in the IRS/FBI fraud investigation of false claims filed to receive settlement money from a 1999 lawsuit against the makers of the diet drug combination ... Jackson Clarion Ledger, Fen-Phen fraud nets 10 months in jail Mar 11, 2005 ...she was sorry for receiving $250,000 for filling a false claim in the diet drug lawsuit settlement. "I will never do this again," Malone said. ... Jackson Clarion Ledger, Fayette woman sentenced to 10 -months in Fen-Phen fraud case Mar 11, 2005 JACKSON, Miss. - A Fayette woman has been sentenced to 10 months in prison for filing a false claim and receiving $250,000 in a diet drug lawsuit settlement. ... Biloxi Sun Herald, ALM's The American Lawyer Examines Fen-Phen Settlement and Finds a ... Mar 1, 2005 After reports that the popular diet drug fen-phen caused damage to heart valves, American Home Products, now Wyeth, pulled its two fen-phen products off the ... Business Wire (press release), Romanowski gets emotion during testimony Mar 8, 2005 In August 2000 he was indicted in Colorado on charges of illegally obtaining the prescription diet drug phentermine to be used as a stimulant. ... Kansas City Star, Judge OKs system of checking and paying fen-phen claims Mar 15, 2005 Harvey J. Bartle gave his long-awaited approval today to a new system of checking and paying claims of certain patients hurt by the diet drug combination known ... philly.com, AROUND THE REGION Mar 12, 2005 JACKSON - A Fayette woman has been sentenced to 10 months in prison for filing a false claim and receiving $250,000 in a diet drug lawsuit settlement. ... SunHerald.com, Ignorance of the law Mar 11, 2005 That’s exactly what happened in Linnen v. Robins, a wrongful death lawsuit filed in May 1997 related to the diet drug popularly known as Fen-phen. ... InfoWorld Care Management for Heart Failure Feb 28, 2005 ...hospitals in which care management produced superior outcomes (1-4). These trials focused on behaviors (exercise, smoking, diet, drug adherence) that were ... Annals of Internal Medicine New champion for child health care Mar 8, 2005 Health Board. Improving immunisation uptake, children's diet, drug, tobacco and alcohol abuse will fall within his remit. Mr Smith ... ic NorthWales, Archived links. These articles may no longer be available. To access these articles you will need to contact the listed source publication (i.e. LA Times, CNN, etc).
Wyeth posts sharp Q3 loss, cites diet drug litigation Oct 22, 2003 Because Wyeth set aside US$2 billion to increase its reserve related to class-action diet drug litigation, the company recorded a net income loss of $426 ... (IDG.com, Singapore) Drug companies feeling sick Oct 26, 2003 Wyeth remained mired in diet-drug litigation costing billions of dollars. Bristol-Myers Squibb Co. warned of a challenging year ahead. ... (Holland Sentinel, MI) NFL inSteroid Net Oct 27, 2003 ...agents Sept. 3. Romanowski previously was scrutinized by the league for trying to acquire a prescription diet drug. Robbins is the ... (Stamford Advocate, CT) Drug stocks falter on pessimistic outlook Oct 22, 2003 Schering-Plough Corp.'s comments on the difficulties in staging a turnaround and Wyeth's announcement of a $2 billion pre-tax charge for continuing diet drug ... (Seattle Post Intelligencer, WA) Drug Stocks Falter on Pessimistic Outlook Oct 22, 2003 Schering-Plough Corp's comments on the difficulties in staging a turnaround and Wyeth's announcement of a $2 billion pre-tax charge for continuing diet drug ... (San Jose Mercury News, CA) Fitch Downgrades Wyeth's Unsecured Rating to 'A-'; Placed on ... Oct 24, 2003 The Rating Watch Negative status will be resolved after discussions with company management regarding further diet drug litigation charges, status of the ... (Business Wire (press release)) Drug companies hit by charges Oct 22, 2003 ...groups reported third-quarter earnings depressed by charges on Wednesday, ranging from Pfizer's costs for integrating Pharmacia, to Wyeth's $2bn diet drug ... (Financial Times (subscription), UK) Tiny profit frees American from losing pattern Oct 23, 2003 ...was Schering-Plough's comments on the difficulties in staging a turnaround and Wyeth's announcement of a $2 billion pretax charge for continuing diet-drug ... (Seattle Times, WA) Pharmaceutical stocks falter Oct 23, 2003 Compounding those losses was Wyeth's announcement of a $2 billion pre-tax charge for continuing diet drug litigation and Schering-Plough Corp's comments on the ... (Salt Lake Tribune, UT) Profit squeezed, Merck to cut jobs Oct 23, 2003 Schering-Plough Corp.'s comments on the difficulties in staging a turnaround and Wyeth's announcement of a $2 billion pretax charge for continuing diet drug ... (Baltimore Sun, MD) Wyeth Posts 3Q Net Loss After Litigation Oct 22, 2003 AP)--Wyeth reported a $426.4 million loss for the third quarter on Wednesday as it took a $2 billion pre-tax charge to increase reserves for its diet drug ... (Atlanta Journal Constitution, GA) Major Drug Producers' Profits Dip Oct 22, 2003 Wyeth reported a $426.4 million loss for the third quarter as it took a $2 billion pretax charge to increase reserves for its diet-drug litigation. ... (Washington Post, DC) Controlled substances in diet pills, police warn Oct 23, 2003 ...regardless of whether they are mixed with phentermine, or had Food and Drug Administration approval."I was scared in the beginning of using just any diet drug ... (The Nation, Thailand, Thailand) Drug makers' earnings trip market Oct 23, 2003 Litigation costs also affected Wyeth, which said it had to pay a charge related to litigation surrounding its diet drug, Redux, which was part of the fen-phen ... (Boston Globe, MA) Drug firms lead market lower Oct 23, 2003 Wyeth also missed Wall Street's forecast, in part because of charges related to diet drug litigation. It lost $2.50, or 5.5 percent, ending the day at $43.30. ... (Indianapolis Star, IN) Results sag at 3 major drug firms Oct 22, 2003 ...products include Advil painkillers, posted a third-quarter loss of $426.4 million as it set aside more money to pay for lawsuits over the fen-phen diet drug ... (International Herald Tribune, France) Drug makers disconnect Oct 22, 2003 ...merger in 1971. In another, Wyeth lost money as it set aside another $2 billion to settle lawsuits from a diet-drug scandal. And in ... (Newark Star Ledger, NJ) Drug makers give investors bad news Oct 23, 2003 Plough Corp.'s comments on its difficulties in staging a turnaround, and Wyeth's announcement of a $2 billion pretax charge related to ongoing diet-drug ... (Akron Beacon Journal, OH) Lowered profit outlook prompts job cuts at Merck Oct 23, 2003 Wyeth reported a $426.4 million loss for the third quarter as it took a $2 billion pre-tax charge to increase reserves for its diet drug litigation. ... (San Diego Union Tribune, CA) Merck, Its Income Shy of Estimates, Plans to Cut Jobs Oct 22, 2003 ...products include Advil, posted a third-quarter loss as it set aside more money to pay for any penalties resulting from lawsuits over the fen-phen diet drug ... (New York Times) Wyeth, Pfizer stand out in drug sector Oct 22, 2003 ...of 65 cents a share before a $2 billion charge to boost the reserve to cover litigation relating to its Redux and Pondimin, part of the once-popular diet drug ... (MSN Money) Merck Posts Weak Earnings; Plans 4,400 Job Cuts Oct 22, 2003 Wyeth, whose products include Advil painkillers, posted a third-quarter loss, as it set aside more money to pay for lawsuits over the fen-phen diet drug ... (New York Times) Merck plans job cuts as its earnings remain sluggish Oct 23, 2003 Pharmacia. Wyeth posted a third-quarter loss, as it set aside more money to pay for lawsuits over the fen-phen diet drug combination. ... (Taipei Times, Taiwan) Merck drags others down Oct 23, 2003 ...was Schering-Plough Corp's comments on the difficulties in staging a turnaround and Wyeth's announcement of a $2 billion pretax charge for continuing diet drug ... (Cincinnati Enquirer, OH) Stocks fall on earnings letdown Oct 22, 2003 Wyeth also missed Wall Street's forecast, in part due to charges related to its diet drug litigation. It was down $2.95, or 6.4 percent, at $42.85. ... (Boston Herald, MA) US stocks take a tumble Oct 22, 2003 Wyeth also missed Wall Street's forecast, in part due to charges related to its diet drug litigation. It lost $2.50, or 5.5 per cent, ending the day at $43.30. ... (The Age, Australia) US Stocks Fall Oct 22, 2003 Wyeth also missed Wall Street’s forecast, in part due to charges related to its diet drug litigation. It lost 2.50, or 5.5%, ending the day at 43.30. ... (The Scotsman, UK) Stocks fall on earnings letdown Oct 22, 2003 Wyeth also missed Wall Street's forecast, in part due to charges related to its diet drug litigation. It was down $3.23, or 7.1 percent, at $42.57. ... (San Diego Union Tribune, CA) US stocks fall on earnings letdown Oct 22, 2003 Wyeth also missed Wall Street's forecast, in part due to charges related to its diet drug litigation. It lost $2.50, or 5.5 percent, ending the day at $43.30. ... (The Star, Malaysia) Wyeth Posts 3Q Net Loss After Litigation Oct 22, 2003 NEW YORK (AP)--Wyeth reported a third quarter net loss Wednesday as it took a $2 billion pre-tax charge to increase reserves for its diet drug litigation. ... (Atlanta Journal Constitution, GA) Dow ends down 149, Nasdaq drops 43 Oct 22, 2003 Wyeth also missed Wall Street's forecast, in part due to charges related to diet drug litigation. It lost $2.50, or 5.5 percent, ending the day at $43.30. ... (San Jose Mercury News, CA) Bonds Prices End Higher Oct 22, 2003 ...analysts' expectations. Wyeth also missed Wall Street's estimate, in part due to charges related to diet drug litigation. In other ... (Atlanta Journal Constitution, GA) Business News Briefs Oct 23, 2003 Plough Corp.’s comments on the difficulties in staging a turnaround and Wyeth’s announcement of a $2 billion pretax charge for continuing diet drug ... (Nashua Telegraph, NH) Strong sales boost Lilly Q3 earnings Oct 22, 2003 ...related to its acquisition of Pharmacia Corp., Wyeth posted a sharp net income loss because it had to set aside a $2 billion reserve for ongoing diet drug ... (IDG.com, Singapore) Dow Down 123, Nasdaq Down 34 Oct 22, 2003 Wyeth also reported a loss, in part due to charges related to its diet drug litigation. It was down $2.54, or 5.6 percent, at $43,26. ... (Springfield News Sun, OH) Pharmaceutical earnings spur stock decline Oct 22, 2003 Wyeth also missed Wall Street's forecast, in part because of charges related to diet-drug litigation. It lost $2.50, or 5.5 percent, ending the day at $43.30. ... (Richmond Times Dispatch, VA) Dow drops 149 points Oct 23, 2003 Wyeth also missed Wall Street's forecast, in part due to charges related to diet-drug litigation. It lost $2.50, ending the day at $43.30. ... (Raleigh News, NC) Investors disappointed by pharmaceuticals Oct 23, 2003 Wyeth also missed Wall Street’s forecast, in part due to charges related to diet drug litigation. It lost $2.50, or 5.5 percent, ending the day at $43.30. (New Haven Register, CT) Wall Street: Wednesday close Oct 23, 2003 Wyeth also missed Wall Street's forecast, in part due to charges related to its diet drug litigation. It lost $2.50, or 5.5%, ending the day at $43.30. ... (This is London, UK) Wyeth Posts 3Q Net Loss After Litigation Oct 22, 2003 NEW YORK - Wyeth reported a third quarter net loss Wednesday as it took a $2 billion pre-tax charge to increase reserves for its diet drug litigation. ... (Washington Post, DC) Wyeth Posts 3Q Net Loss After Litigation Oct 22, 2003 NEW YORK -- Wyeth reported a third quarter net loss Wednesday as it took a $2 billion pre-tax charge to increase reserves for its diet drug litigation. ... (Newsday) Lawyers target of latest batch of fen-phen cases Oct 13, 2003 JACKSON - The lawyers who went after the makers of the diet drug fen-phen have felt the heat from several backlash lawsuits spurring from the multimillion ... (Hattiesburg American, MS) Judge orders attorney to stop lawsuits Oct 13, 2003 The lawyers who went after the makers of the diet drug fen-phen have felt the heat from several backlash lawsuits spurring from the multimillion-dollar ... (Jackson Clarion Ledger, MS) Daily Commentary from SIR Highlights the Following Stocks: Wyeth ... Oct 23, 2003 WYE). The company reported earnings before the open yesterday that showed a $2-billion charge due to continued diet drug litigation. ... (Business Wire (press release)) Daily Commentary from SIR Highlights the Following Stocks: Wyeth ... Oct 23, 2003 One example is Wyeth (NYSE:WYE). The company reported earnings before the open yesterday that showed a $2-billion charge due to continued diet drug litigation. ... (Business Wire (press release)) United we stand Oct 23, 2003 But it also looks at issues like diet, drug and alcohol awareness, avoidance of gambling and how to interact with people from other walks of life. ... (ThisIsLeeds.co.uk, UK) Capital One 3rd-quarter profit rises Oct 22, 2003 Wyeth reported a $426.4 million loss for the third quarter as it took a $2 billion pre-tax charge to increase reserves for its diet-drug litigation. ... (Richmond Times Dispatch, VA) Wyeth Posts 3Q Net Loss After Litigation Oct 22, 2003 YORK - Wyeth reported a $426.4 million loss for the third quarter on Wednesday as it took a $2 billion pre-tax charge to increase reserves for its diet drug ... (Fort Wayne News Sentinel, IN) Even if you don't lose weight, exercise and a healthy diet pay ... Oct 20, 2003 Health-spa ads that show a roomful of aerobicized women carrying 3 percent body fat. Diet-drug pitches that show a size-2 woman as the "before" picture. ... (Fort Worth Star Telegram, TX) Merck to cut 4400 jobs after Q3 disappoints Oct 22, 2003 ...loss of $426.4m, after being forced to go back on promises that it had taken enough provisions to cover litigation over damage caused by its fen-phen diet drug ... (Financial Times (subscription), UK) Dow Drops 149, Nasdaq Drops 38 Oct 22, 2003 Wyeth also missed Wall Street's forecast, in part due to charges related to its diet drug litigation. It was down $2.19, or 4.8 percent, at $43.61. ... (Rapid City Journal, SD) Stocks decline on earnings letdown Oct 22, 2003 ...at $15.12. Wyeth (NYSE: WYE) also missed Wall Street's forecast, in part due to charges related to diet drug litigation. It lost ... (San Diego Daily Transcript, CA) Wyeth Posts 3Q Net Loss After Litigation Oct 22, 2003 ...by THERESA AGOVINO. Wyeth reported a third quarter net loss Wednesday as it took a $2 billion pre-tax charge to increase reserves for its diet drug litigation. ... (Times Daily, AL) |
